Cutler Group LP Sarepta Therapeutics, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 6,900 shares of SRPT stock, worth $896,034. This represents 0.29% of its overall portfolio holdings.
Number of Shares
6,900
Previous 18,534
62.77%
Holding current value
$896,034
Previous $1.79 Million
50.03%
% of portfolio
0.29%
Previous 0.16%
Shares
25 transactions
Others Institutions Holding SRPT
# of Institutions
470Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA8.8MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$774 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.89MShares$635 Million0.36% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$626 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$564 Million6.78% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...